--Antibody-based Bulk Reagents, MINITube assays, Germination Media and Diluent

The U.S. Army Space and Missile Defense Command, representing the U.S. Critical Reagents Program, plans to award a sole source contract to BioVeris Corporation for the supply of antibody-based bulk reagents, MINITube assays, and small quantities of germination media and diluent. BioVeris is uniquely qualified and the only known provider capable of producing the necessary reagents compatible with Government-owned ECL Technology and analyzers such as the M-SERIES M-8, M1R, and M1M, which are utilized at the National Capital Region Silver Standard Laboratory and other designated JPEO-CBD sites. The contract is expected to operate under an Indefinite Delivery, Indefinite Quantity (IDIQ) structure, including modifications for three remaining option years. The announcement invites any other parties with comparable credentials and capabilities to submit factual evidence supporting their qualifications by July 16, 2004. This procurement supports specialized assay analysis needs critical to defense operations and reflects the government’s reliance on BioVeris’ proprietary technology and product compatibility. Questions regarding the opportunity are directed to the identified contracting officers at the U.S. Army Medical Department. The procurement falls under NAICS code 334519 and is managed within the Department of Defense framework at Redstone Arsenal, Alabama.